CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: Systematic review and meta-analysis

Tohoku Journal of Experimental Medicine

Volumn 232, Issue 1, 2014, Pages 9-19

  Chai, Liang ^a   Liu, Hongyan ^a   Zhang, Zhili ^a   Wang, Feng ^a   Wang, Qingying ^a   Zhou, Shuihong ^a   Wang, Shenqing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD44; Laryngeal cancer; Meta analysis; Pharyngeal cancer; Prognosis

Indexed keywords

CD44V ANTIGEN; CD44V6 ANTIGEN; ISOPROTEIN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; CORRELATION ANALYSIS; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PATHOLOGY; PHARYNGOLARYNGEAL CANCER; PHARYNX CANCER; PREDICTIVE VALUE; PREDICTOR VARIABLE; SYSTEMATIC REVIEW; TUMOR VOLUME;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; OBSERVATIONAL STUDY AS TOPIC; PHARYNGEAL NEOPLASMS; PROGNOSIS; PROTEIN ISOFORMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84893151773     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.232.9     Document Type: Article

References (54)

1. Amirghofran, Z., Jalali, S.A., Hosseini, S.V., Vasei, M., Sabayan, B. & Ghaderi, A. (2008) Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. J. Gastrointest. Cancer, 39, 73-78.
2. Andratschke, M., Chaubal, S., Pauli, C., Mack, B., Hagedorn, H. & Wollenberg, B. (2005) Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer. Anticancer Res., 25, 2821-2826.
3. Bourguignon, L.Y., Singleton, P.A., Diedrich, F., Stern, R. & Gilad, E. (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem., 279, 26991-27007.
4. Brown, R.L., Reinke, L.M., Damerow, M.S., Perez, D., Chodosh, L.A., Yang, J. & Cheng, C. (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J. Clin. Invest., 121, 1064-1074.
5. Esteban, F., Bravo, J.J., Gonzalez-Moles, M.A., Bravo, M., Ruiz-Avila, I. & Gil-Montoya, J.A. (2005) Adhesion molecule CD44 as a prognostic factor in laryngeal cancer. Anticancer Res., 25, 1115-1121.
6. Faber, A., Barth, C., Hormann, K., Kassner, S., Schultz, J.D., Sommer, U., Stern-Straeter, J., Thorn, C. & Goessler, U.R. (2011) CD44 as a stem cell marker in head and neck squamous cell carcinoma. Oncol. Rep., 26, 321-326.
7. Fehon, R.G., McClatchey, A.I. & Bretscher, A. (2010) Organizing the cell cortex: the role of ERM proteins. Nat. Rev. Mol. Cell Biol., 11, 276-287.
8. Fox, S.B., Fawcett, J., Jackson, D.G., Collins, I., Gatter, K.C., Harris, A.L., Gearing, A. & Simmons, D.L. (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546.
9. Franzmann, E.J., Reategui, E.P., Pedroso, F., Pernas, F.G., Karakullukcu, B.M., Carraway, K.L., Hamilton, K., Singal, R. & Goodwin, W.J. (2007) Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol. Biomarkers Prev., 16, 1348-1355.
10. Gallatin, W.M., Weissman, I.L. & Butcher, E.C. (1983) A cellsurface molecule involved in organ-specific homing of lymphocytes. Nature, 304, 30-34.
11. Gao, Y. (2009) The expression and its significance of CD44v6 in human laryngeal and hypopharyngeal squamous cell carcinoma. Chi. Med. Herald, 6, 76-77.
12. Guo, X., Li, X., Li, F., Feng, S., Li, X., Pan, Z., Guan, C., Wang, Y., Yang, H. & Jiang, X. (2009) Expression of gene BRMS1 and CD44v6 protein in supraglottic laryngeal carcinoma and its clinical significance. J. Clin. Otorhinolaryngol. Head and Neck Surg. (China), 23, 249-253.
13. Huang, S., Luo, W., Wu, S., Wang, W. & Chen, X. (2007) Expression of PCNA and CD44V6 in laryngeal carcinoma. J. Guangdong Med. coll., 2, 142-144.
14. Janisiewicz, A.M., Shin, J.H., Murillo-Sauca, O., Kwok, S., Le, Q.T., Kong, C., Kaplan, M.J. & Sunwoo, J.B. (2012) CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int. Forum Allergy Rhinol., 2, 465-470.
15. Kawano, T., Nakamura, Y., Yanoma, S., Kubota, A., Furukawa, M., Miyagi, Y. & Tsukuda, M. (2004) Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx, 31, 35-41.
16. Kawano, T., Yanoma, S., Nakamura, Y., Ozeki, A., Kokatsu, T., Kubota, A., Furukawa, M. & Tsukuda, M. (2005) Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer. Acta Otolaryngol., 125, 392-397.
17. Kittl, E.M., Ruckser, R., Selleny, S., Samek, V., Hofmann, J., Huber, K., Reiner, A., Ogris, E., Hinterberger, W. & Bauer, K. (1997) Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients. Exp. Clin. Immunogenet., 14, 264-272.
18. Kokko, L.L., Hurme, S., Maula, S.M., Alanen, K., Grenman, R., Kinnunen, I. & Ventela, S. (2011) Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol., 47, 510-516.
19. Krishnamachary, B., Penet, M.F., Nimmagadda, S., Mironchik, Y., Raman, V., Solaiyappan, M., Semenza, G.L., Pomper, M.G. & Bhujwalla, Z.M. (2012) Hypoxia regulates CD44 and its variant isoforms through HIF-1alpha in triple negative breast cancer. PLoS One, 7, e44078.
20. Lamontagne, C.A. & Grandbois, M. (2008) PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells. Exp. Cell Res., 314, 227-236.
21. Lee, J.H., Kim, S.H., Lee, E.S. & Kim, Y.S. (2009) CD24 overexpression in cancer development and progression: a meta-analysis. Oncol. Rep., 22, 1149-1156.
22. Leung, E.L., Fiscus, R.R., Tung, J.W., Tin, V.P., Cheng, L.C., Sihoe, A.D., Fink, L.M., Ma, Y. & Wong, M.P. (2010) Nonsmall cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One, 5, e14062.
23. Lu, J., Gao, Y., Xiao, Y. & Jin, D. (2008) Expression and clinical significance of CD44v6 in tissues of laryngeal and hypopharyngeal squamous cell carcinoma. J. Harbin Med. Univ., 42, 142-146.
24. Lu, S., Tian, J., Lv, Z., Wang, H., Bai, X., Liu, W., Li, J. & Xu, W. (2011) The probable role of tumor stem cells for lymph node metastasis in supraglottic carcinoma. Pathol. Oncol. Res., 17, 33-38.
25. Ma, D., Yuan, L., Zhao, Y., Zhou, X., Li, C. & Liu, L. (2009) Relationship study between KAI1, CD44v3 expressions and laryngeal carcinoma. J. Shandong Med. Coll., 31, 87-90.
26. Mima, K., Hayashi, H., Imai, K., Kuroki, H., Nakagawa, S., Okabe, H., Chikamoto, A., Watanabe, M., Beppu, T. & Baba, H. (2013) High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J. Hepatobiliary Pancreat. Sci., 20, 429-434.
27. ML, P. & O, C. (2010) Clinical Analysis of 2666 Cases of Otothinolaryngologic Tumors. J. Jilin Univ., 13, 57.
28. Murata, T., Yasuoka, Y., Shimada, T., Shino, M., Iida, H., Takahashi, K. & Furuya, N. (2011) A new and less invasive procedure for arytenoid adduction surgery: endoscopicassisted arytenoid adduction surgery. Laryngoscope, 121, 1274-1280.
29. Nguyen, L.V., Vanner, R., Dirks, P. & Eaves, C.J. (2012) Cancer stem cells: an evolving concept. Nat. Rev. Cancer, 12, 133-143.
30. Ni, C., Zhang, Z., Zhu, X., Liu, Y., Qu, D., Wu, P., Huang, J. & Xu, A.X. (2013) Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis. PLoS One, 8, e70958.
31. Okamoto, I., Tsuiki, H., Kenyon, L.C., Godwin, A.K., Emlet, D.R., Holgado-Madruga, M., Lanham, I.S., Joynes, C.J., Vo, K.T., Guha, A., Matsumoto, M., Ushio, Y., Saya, H. & Wong, A.J. (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol., 160, 441-447.
32. Piffko, J., Bankfalvi, A., Klauke, K., Dreier, R., Joos, U., Bocker, W. & Schmid, K.W. (1996) Unaltered strong immunohistochemical expression of CD44-v6 and-v5 isoforms during development and progression of oral squamous cell carcinomas. J. Oral Pathol. Med., 25, 502-506.
33. Qiu, X., Huang, J., Zhang, Z., Da, P. & Zhou, R. (2006) The expression of CD44 and its clinical significance in human laryngeal carcinoma. Med. J. Commun., 20, 670-671.
34. Rodrigo, J.P., Dominguez, F., Alvarez, C., Gonzalez, M.V., Herrero, A. & Suarez, C. (2002) Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx. Am. J. Clin. Pathol., 118, 67-72.
35. Rodrigo, J.P., Dominguez, F., Alvarez, C., Herrero, A. & Suarez, C. (2003) Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas. Am. J. Otolaryngol., 24, 384-389.
36. Siegel, R., Naishadham, D. & Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin., 62, 10-29.
37. Song, X., Peng, J., Cai, X., Hou, F. & Lin, Q. (1999) Expression of CD44v6 protein in laryngeal squamous cell carcinoma. Chi. J. Otorhinolaryngology-Skull Base Surg., 5, 76-79.
38. Staibano, S., Merolla, F., Testa, D., Iovine, R., Mascolo, M., Guarino, V., Castellone, M.D., Di Benedetto, M., Galli, V., Motta, S., Melillo, R.M., De Rosa, G., Santoro, M. & Celetti, A. (2007) OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br. J. Cancer, 97, 1545-1551.
39. Stamenkovic, I. & Yu, Q. (2009) Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding. J. Invest. Dermatol., 129, 1321-1324.
40. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., Moher, D., Becker, B.J., Sipe, T.A. & Thacker, S.B. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-2012.
41. Su, Y.J., Lai, H.M., Chang, Y.W., Chen, G.Y. & Lee, J.L. (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J., 30, 3186-3199.
42. Ue, T., Yokozaki, H., Kagai, K., Higashikawa, K., Yasui, W., Sugiyama, M., Tahara, E. & Ishikawa, T. (1998) Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J. Oral Pathol. Med., 27, 197-201.
43. Uwa, N., Kataoka, T.R., Torii, I., Sato, A., Nishigami, T., Song, M., Daimon, T., Saeki, N., Sagawa, K., Mouri, T., Terada, T., Sakagami, M. & Tsujimura, T. (2011) CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma. Acta Otolaryngol., 131, 323-329.
44. van der Windt, G.J., Schouten, M., Zeerleder, S., Florquin, S. & van der Poll, T. (2011) CD44 is protective during hyperoxiainduced lung injury. Am. J. Respir. Cell Mol. Biol., 44, 377-383.
45. Van Hal, N.L., Van Dongen, G.A., Ten Brink, C.B., Heider, K.H., Rech-Weichselbraun, I., Snow, G.B. & Brakenhoff, R.H. (1999) Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. Clin. Cancer Res., 5, 3534-3541.
46. Wang, K., Xu, J., Zhang, J. & Huang, J. (2012) Prognostic role of CD133 expression in colorectal cancer: a meta-analysis. BMC Cancer, 12, 573.
47. Wang, M., Xing, L. & Zhang, C. (2004) Study in the expression of CD44 in nasopharyngeal neoplasms and the clinical relationship. Tianjin Med. J., 32, 535-537.
48. Wang, S.L., Yang, Q., Xiao, B.K., Jiang, Y.S. & Chen, E.H. (2000) Expression of CD44s and CD44v6 in laryngeal squamous cell carcinoma and their significance. J. Clin. Otorhinolaryngol (China), 14, 446-448.
49. Xu, Y.P., Zhao, X.Q., Sommer, K. & Moubayed, P. (2003) Correlation of matrix metalloproteinase-2,-9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis. J. Zhejiang Univ. Sci., 4, 491-501.
50. Yamane, N., Tsujitani, S., Makino, M., Maeta, M. & Kaibara, N. (1999) Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology, 56, 232-238.
51. Yuce, I., Bayram, A., Cagli, S., Canoz, O., Bayram, S. & Guney, E. (2011) The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma. Am. J. Otolaryngol., 32, 141-146.
52. Zhao, S., Sun, B., He, J., Ye, Q., Lin, S. & Sun, A. (2003) The expression of CD44 and its significance in human laryngeal carcinoma. J. Clin. Otorhinolaryngol. (China), 17, 164-166.
53. Zhu, J., Fedewa, S. & Chen, A.Y. (2012) The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008). Arch. Otolaryngol. Head Neck Surg., 138, 1120-1128.
54. Zoller, M. (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer, 11, 254-267.